SEBI Reg. Investment Advisor

Download App
Help Center Pricing
Money Works 4 Me Logo MoneyWorks4Me
Login Get Free Account
Sign Up

MoneyWorks4Me

Log In Sign Up Schedule Free 15‑min Call
Login Get Free Account
Sign Up

INVESTMENT INSIGHTS

Check Before You Invest : Astonea Labs Ltd

BSE: 544409 NSE: ISIN: INE0TG901011
  |   Sector:  Healthcare   |   Industry:  Pharmaceuticals & Drugs

Snapshot

Q.1 Which industry/sub-sector does Astonea Labs Ltd belong to?
Astonea Labs Ltd belongs to the Healthcare sector, operating specifically within the Pharmaceuticals & Drugs segment.
Q.2 Is Astonea Labs Ltd a good quality company?
Astonea Labs Ltd is a weak quality company, based on a inconsistent 10 year financial track record.
Q.3 Is Astonea Labs Ltd undervalued or overvalued?
Astonea Labs Ltd appears Undervalued, as its key valuation ratios are below with their past averages.
Q.4 Is Astonea Labs Ltd a good buy now?
Astonea Labs Ltd is not a good buy now, based on weak price trend analysis suggesting prices may fall. However, you need to check its quality and valuation before making a decision

Performance Analysis

Q.1 Revenue growth of Astonea Labs Ltd?
Astonea Labs Ltd revenue growth is 21.6% for FY-2025 , which is above its 5 year CAGR of 0% , indicating faster growth.
Q.2 Gross Profit margin of Astonea Labs Ltd?
Astonea Labs Ltd Gross profit margin which is the profit after deduction of direct costs, is 12% for FY-2025 , which is below its 5 year median of 12.9% , indicating decreasing margins.
Q.3 Operating Profit Margin of Astonea Labs Ltd?
Astonea Labs Ltd Operating Profit Margin which is the profit after deduction of all operating costs, is 15.69% for FY-2025 , which is below its 5 year median of 17.12% indicating decreasing margins.
Q.4 Net Profit Margin of Astonea Labs Ltd?
Astonea Labs Ltd Net Profit Margin is 5.49% for FY-2025 , is above with its 5 year median of 3.24%, indicating increasing margins.
Current Level Historic Median
Gross Profit Margin 12 12.9
Operating Profit Margin 15.69 17.12
Net Profit Margin 5.49 3.24
Q.5 Return on Asset of Astonea Labs Ltd?
Astonea Labs Ltd Return on Asset is 5.78%, which is above its 5 year historical median of 3.46%, indicating improved asset utilization efficiency.
Q.6 Return on Equity (ROE) of Astonea Labs Ltd?
Astonea Labs Ltd Return on equity is 35.36% for FY-2025 , which is above its historical median of 24.59%, indicating the business is making better use of its shareholders capital.
Q.7 Return on capital employed (ROCE) of Astonea Labs Ltd?
Astonea Labs Ltd Return on capital employed is 17.31% for FY-2025 , which is above its estimated weighted average cost of capital(WACC) 14%, indicating value creation.
Q.8 Cash conversion cycle of Astonea Labs Ltd?
Astonea Labs Ltd Cash conversion cycle is 114 days, above its historical median of 97 days, indicating deteriorated working capital management. However, you need to compare this with its peers in the industry.
Current Level Historic Median
Asset Turnover 1.05 1.1
ROE 35.36 24.59
ROCE 17.31 12.87
Cash Conversion Cycle 114 days 97 days
Q.9 Debt to Equity ratio of Astonea Labs Ltd?
Astonea Labs Ltd Debt-to-Equity ratio is 2.90 , which is above with the industry average of 0.15 , indicating higher debt levels in the industry.
Q.10 Debt to cash flow from operations of Astonea Labs Ltd?
Astonea Labs Ltd Debt to cash flow from operations is 5.77 , which is at a unhealthy level.

Ownership & governance

Q.1 Promoter shareholding and pledge status of Astonea Labs Ltd?
Promoters hold 72.30% of the Astonea Labs Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Peer comparison (industry-wise, mcap)

Q.1 Revenue growth of Astonea Labs Ltd vs industry peers?
Astonea Labs Ltd revenue CAGR is 0.00% , compared to the industry median CAGR of 5.54% , indicating stable growth and maintaining its market share.
Profit Metrics
Current Level Industry Median
Revenue 97.5 137.1
Gross Profit 11.8 15.1
Operating Profit 15 16
Net Profit 5 5.6
Operating Efficiency
Current Level Industry Median
Asset Turnover 1.05 0.8
ROE 35.36 8.91
ROCE 17.31 11.59
Cash Conversion Cycle (days) 114.02 76

Valuation & price assessment

Q.1 Stock return of Astonea Labs Ltd over the last decade?
Over the last - year(s), the stock has delivered a CAGR of N/A% based on the current price.
Q.2 What return has the stock given over the last decade?
9Y 5Y 3Y 1Y
Share Price - - - -
Q.3 Valuation ratios of Astonea Labs Ltd vs historical?
The current P/E is higher that its historical median.
Q.4 How do the current valuation ratios measure up against the historic numbers and the current industry numbers?
Valuation Ratios Current Historic Median Industry Median
Price to Earnings 30.45 0.00 40.28
Price to Book 2.91 2.97 2.77
Price to Sales 1.67 0.00 2.65
EV to EBITDA 13.96 0.00 15.67

Check more companies

1. Ajanta Pharma
2. JB Chem & Pharma
3. Emcure Pharma
4. Gland Pharma
5. Wockhardt
6. Pfizer
7. Astrazeneca Pharma I
8. Sai Life Sciences
9. Natco Pharma
10. Eris Lifesciences
2026 ©The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me® is a registered trademark of The Alchemists Ark Pvt. Ltd.

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×